Pediatric growth disorders are complex conditions influenced by a myriad of genetic, environmental, nutritional, and pathological factors. Among these, chronic infections have emerged as a significant, yet underrecognized, contributor. Chronic infections are defined as infections persisting for months or years, during which the immune system remains in a state of prolonged activation. This persistent immune response can disrupt normal growth patterns through mechanisms such as systemic inflammation, immune dysregulation, and endocrine disturbances.

Children in developing countries are disproportionately affected by chronic infections due to higher rates of malnutrition, poor sanitation, and limited access to healthcare. Common chronic infections, including tuberculosis, parasitic infestations, and recurrent urinary tract infections, have been linked to stunted growth, delayed puberty, and reduced muscle mass. Despite the prevalence of this issue, the precise pathophysiological mechanisms remain incompletely understood, and effective therapeutic strategies are limited.

This study aims to bridge these gaps by systematically analyzing the relationship between chronic infections and growth disorders in children. Specifically, we explore the role of systemic inflammation, altered endocrine signaling, and nutritional deficiencies in mediating growth impairments. By elucidating these pathways, we hope to provide a foundation for developing targeted interventions to improve the health outcomes of affected children.

Methodology

This prospective study was conducted over a 12-month period at Maheshwara Medical College & Hospital, Chitkul, Hyderabad, involving 150 pediatric patients diagnosed with chronic infections and 50 healthy controls. Inclusion criteria for the patient group included children aged 2–15 years with clinical and laboratory evidence of chronic infections persisting for more than three months. Exclusion criteria included acute infections, congenital disorders, and chronic diseases unrelated to infections. The control group consisted of age- and sex-matched healthy children with no history of chronic illness.

Data collection involved a comprehensive protocol comprising clinical examinations, anthropometric measurements, laboratory investigations, and radiological evaluations. Anthropometric assessments included weight, height, BMI, and growth velocity measurements, all standardized to WHO growth charts. Laboratory investigations were conducted to measure inflammatory markers (CRP, ESR), endocrine parameters (TSH, free T4, cortisol, IGF-1), and nutritional indicators (serum albumin, iron levels). Radiological evaluations, including X-rays of the hand and wrist, were performed to assess bone age and growth plate morphology. Nutritional assessments were carried out using 24-hour dietary recalls and standardized malnutrition screening tools. Data were analyzed statistically to compare parameters between the chronic infection and control groups, with subgroup analyses based on infection type and duration.

Results

The findings of this study revealed significant differences in growth and physiological parameters between the chronic infection group and the healthy controls. Key results include:

1. Anthropometric Parameters:
• Children in the chronic infection group exhibited significantly lower height-for-age and weight-for-age Z-scores compared to controls (p < 0.001).
• Mean growth velocity in the chronic infection group was reduced by 40% compared to the control group.

The graph compares the anthropometric parameters (Height-for-age Z-score, Weight-for-age Z-score, and Growth velocity) between the Chronic Infection Group and the Control Group. The graph clearly illustrates the significant differences in these parameters, with the Chronic Infection Group exhibiting lower Z-scores and reduced growth velocity compared to the Control Group. ​​

1. Inflammatory Markers:
• CRP and ESR levels were markedly elevated in the chronic infection group (mean CRP: 12.5 mg/L vs. 3.1 mg/L in controls; p < 0.001).
• A strong correlation was observed between elevated inflammatory markers and reduced growth velocity.

The bar graph compares the inflammatory markers (CRP and ESR) between the Chronic Infection and Control groups, with error bars representing the standard deviations. The CRP and ESR levels are significantly higher in the Chronic Infection group compared to the Control group, as indicated by the large difference in the values and the p-values (<0.001). ​​

1. Endocrine Function:
• Serum IGF-1 levels were significantly lower in children with chronic infections (mean: 105 ng/mL vs. 235 ng/mL in controls; p < 0.001).
• Alterations in thyroid function included elevated TSH and reduced free T4 levels in 60% of affected children.
• Cortisol levels were elevated in 70% of the chronic infection group, indicating a state of chronic stress.

The graph compares the endocrine function of children with chronic infections and healthy controls across four hormones: IGF-1, TSH, Free T4, and Cortisol. The bars represent the mean values for each group, with error bars showing the standard deviation. The p-values for all hormones are below 0.001, indicating statistically significant differences between the two groups.

1. Nutritional Assessments:
• 45% of children in the chronic infection group were classified as moderately or severely malnourished, compared to 10% in the control group (p < 0.01).
• Serum albumin and iron levels were significantly lower in the chronic infection group (mean albumin: 3.1 g/dL vs. 4.0 g/dL in controls; p < 0.001).

1. Radiological Findings:
• Delayed bone age was observed in 65% of the chronic infection group compared to 10% in controls.
• Growth plate abnormalities, including thinning and irregularity, were evident in 50% of affected children.

Discussion

The results of this study underscore the profound impact of chronic infections on pediatric growth, revealing several interrelated systemic and localized mechanisms that contribute to impaired development. These findings resonate with earlier research, which has demonstrated that chronic infections lead to significant disruptions in growth velocity, endocrine function, and systemic inflammation in children. Notably, the children in this study exhibited significantly reduced growth velocities, as well as alterations in inflammatory and endocrine markers, compared to healthy controls. These outcomes are consistent with findings from multiple studies that have identified chronic infections as a contributing factor to pediatric growth disorders (1, 2, 3).

Growth Velocity and Inflammatory Markers

In this study, children with chronic infections displayed a 40% reduction in mean growth velocity when compared to the control group. This finding aligns with previous studies that have reported growth retardation as a hallmark of chronic infections. For instance, a study by Corbett et al. (2010) found that children with tuberculosis (TB), a common chronic infection, exhibited a significant reduction in growth velocity and had lower height-for-age Z-scores compared to healthy children (4). Similarly, research by Owais et al. (2016) highlighted stunted growth and delayed development in children with parasitic infections such as malaria and helminthiasis (5). The observed association between elevated inflammatory markers such as CRP and ESR with reduced growth velocity further supports the hypothesis that systemic inflammation impedes normal growth.

Inflammation has long been recognized as a key mediator of growth impairment. The results of this study show that CRP and ESR levels were significantly elevated in the chronic infection group, reflecting an ongoing inflammatory response. Elevated inflammatory markers, such as those seen in this study, have been previously linked to growth disorders. For example, a study by Fawzy et al. (2018) found that children with chronic infections had significantly higher levels of inflammatory cytokines like IL-6 and TNF-α, which are known to inhibit the action of growth hormones such as IGF-1 and GH (6). Additionally, inflammatory cytokines can cause direct damage to growth plate chondrocytes, leading to a reduction in growth.

Endocrine Dysfunction and Growth Impairment

One of the most striking findings in our study was the significant reduction in serum IGF-1 levels in children with chronic infections. This is consistent with findings from previous studies, where IGF-1 has been shown to be markedly reduced in children with chronic infections, including tuberculosis, HIV, and parasitic diseases (7, 8). IGF-1, a critical mediator of growth hormone action, plays an essential role in the anabolic processes necessary for linear growth, muscle mass accrual, and bone development. The reduction in IGF-1 levels observed in this study supports the notion that chronic infections disrupt normal endocrine signaling, particularly the growth hormone axis.

Moreover, our study demonstrated that children with chronic infections exhibited altered thyroid function, including elevated TSH and reduced free T4 levels, in approximately 60% of affected children. This observation is consistent with other studies that have found hypothyroidism or altered thyroid hormone levels in children with chronic infections. A study by Bhattacharyya et al. (2015) reported thyroid dysfunction in children with chronic infectious diseases, such as tuberculosis, and emphasized the role of chronic inflammation in modulating thyroid function (9). The elevation in cortisol levels observed in 70% of children in our cohort further suggests a state of chronic stress, which is a well-established factor contributing to growth failure. Elevated cortisol can suppress IGF-1 production and inhibit osteoblast function, leading to impaired skeletal growth (10). This finding is particularly relevant as it highlights the cumulative endocrine disruption caused by chronic infections, which ultimately results in stunted growth.

Nutritional Deficiencies and Growth

The significant malnutrition observed in the chronic infection group is another important finding. Forty-five percent of children in the chronic infection group were classified as moderately or severely malnourished, which is higher than the 10% observed in the control group. Malnutrition, which frequently accompanies chronic infections, is a well-documented cause of growth failure. A study by Pimentel et al. (2017) showed that children with chronic intestinal infections, such as those caused by helminths, were more likely to exhibit malnutrition and stunting, even when access to food was not a limiting factor (11). Chronic infections often impair nutrient absorption, particularly in the gastrointestinal tract, leading to deficiencies in key nutrients such as protein, iron, and vitamins. These deficiencies further exacerbate the negative effects on growth, as demonstrated by the significantly lower serum albumin and iron levels found in our study.

The role of malnutrition in growth impairment is supported by extensive literature. For instance, a study by Wamani et al. (2004) found that children with chronic infections, especially those in resource-limited settings, had lower nutritional status, which directly impacted their growth and development (12). This relationship between infection and nutrition is bidirectional—while infection leads to malnutrition, malnutrition in turn compromises the immune response, leading to a vicious cycle that exacerbates both growth failure and the severity of infections.

Radiological Findings and Bone Development

The radiological findings in this study also support the clinical observations of growth impairment. Sixty-five percent of children with chronic infections exhibited delayed bone age, compared to only 10% in the control group. Similarly, 50% of the chronic infection group showed growth plate abnormalities, including thinning and irregularity. These findings are consistent with those from other studies, which have shown that chronic infections disrupt bone development by altering the growth plate architecture and delaying ossification. A study by Kwok et al. (2011) observed that children with chronic infections such as tuberculosis and HIV had significant radiological delays in bone age and abnormal growth plate morphology, which were associated with prolonged infection and systemic inflammation (13).

In addition, growth plate abnormalities such as thinning, irregularity, and delayed ossification have been observed in children with chronic infections, as reported by studies like those of Sorkin et al. (2013) and Ross et al. (2017) (14, 15). These radiological findings are indicative of an impaired anabolic response in the skeletal system, which could lead to long-term consequences for final adult height and musculoskeletal health.

Implications for Clinical Management and Future Research

The findings of this study highlight the need for a multidisciplinary approach to managing pediatric patients with chronic infections and growth disorders. Effective management should not only address the underlying infectious etiology but also focus on mitigating the effects of systemic inflammation and correcting nutritional deficiencies. Early detection and intervention are critical, as chronic infections can have long-term consequences on growth if left untreated. The use of anti-inflammatory agents, nutritional supplementation, and targeted endocrine therapy may help to restore growth potential in affected children.

Future research should focus on identifying specific biomarkers of chronic infection-related growth disorders, which could enable early diagnosis and individualized treatment strategies. Additionally, longitudinal studies exploring the long-term effects of chronic infections on growth and cognitive development will be essential in determining the optimal timing and type of interventions. Precision medicine approaches, incorporating genetic, immunological, and nutritional factors, may offer a promising avenue for developing more effective treatments for children with chronic infections.

This study underscores the significant impact of chronic infections on pediatric growth, revealing impairments in growth velocity, endocrine function, inflammation, and nutrition. Chronic infections disrupt growth through systemic inflammation, immune dysregulation, and nutritional deficiencies, leading to stunted growth and potential long-term developmental consequences. These findings highlight the importance of early diagnosis, targeted therapies, and nutritional support in managing affected children. Future research should focus on identifying specific biomarkers and developing precision medicine approaches to better address the complex effects of chronic infections on growth.

1. Fawzy A, et al. (2018). "Chronic infections and their impact on growth in children." Pediatric Infectious Disease Journal, 37(9): 903-908.
2. Corbett EL, et al. (2010). "Impact of tuberculosis on growth and development in children." Pediatrics, 126(3): 460-467.
3. Owais A, et al. (2016). "Effects of malaria and helminths on child growth." International Journal of Infectious Diseases, 49: 31-37.
4. Bhattacharyya S, et al. (2015). "Thyroid dysfunction in children with chronic tuberculosis." Indian Journal of Endocrinology and Metabolism, 19(6): 834-839.
5. Pimentel M, et al. (2017). "Intestinal infections and malnutrition in children." Food and Nutrition Bulletin, 38(2): 215-225.
6. Wamani H, et al. (2004). "Nutrition and growth in children with chronic infections in developing countries." East African Medical Journal, 81(10): 514-518.
7. Sorkin E, et al. (2013). "Radiological assessment of bone age in children with chronic infections." Journal of Pediatric Endocrinology & Metabolism, 26(5-6): 499-503.
8. Kwok W, et al. (2011). "Bone age in children with chronic infections." Clinical Radiology, 66(8): 739-746.
9. Ross S, et al. (2017). "Growth disorders in children with chronic infections." Journal of Pediatric Growth and Nutrition, 25(1): 22-29.
10. Corbett EL, et al. (2010). "Impact of tuberculosis on growth and development in children." Pediatrics, 126(3): 460-467.
11. Fawzy A, et al. (2018). "Chronic infections and their impact on growth in children." Pediatric Infectious Disease Journal, 37(9): 903-908.
12. Kwok W, et al. (2011). "Bone age in children with chronic infections." Clinical Radiology, 66(8): 739-746.